• Publications
  • Influence
ST-segment elevation myocardial infarction due to early and late stent thrombosis a new group of high-risk patients.
OBJECTIVES The aim of this retrospective study was to compare clinical and angiographic outcomes between patients presenting with ST-segment elevation myocardial infarction (STEMI) due to stentExpand
  • 100
  • 3
Incidence, predictors, and outcomes of coronary dissections left untreated after drug-eluting stent implantation.
AIMS Coronary dissections left untreated after percutaneous coronary intervention are associated with unfavourable outcomes. However, their role after drug-eluting stent (DES) implantation is stillExpand
  • 93
  • 3
  • PDF
Single-center randomized evaluation of paclitaxel-eluting versus conventional stent in acute myocardial infarction (SELECTION).
OBJECTIVES To evaluate the superiority of the paclitaxel-eluting stent (PES) in reducing neointimal hyperplasia (NIH) over its corresponding bare metal stent (BMS) during primary percutaneousExpand
  • 64
  • 3
Validation of predictors of intraprocedural stent thrombosis in the drug-eluting stent era.
Although predictors of acute intraprocedural stent thrombosis (IPST) in the drug-eluting stent era have been proposed, external validation is lacking. We thus analyzed the occurrence of IPST in theExpand
  • 39
  • 2
European Initial Hands-On Experience with HEMOPATCH, a Novel Sealing Hemostatic Patch: Application in General, Gastrointestinal, Biliopancreatic, Cardiac, and Urologic Surgery.
Topical hemostatic agents that can seal tissues and assist in the coagulation cascade of patients undergoing surgery have been readily available for several decades. Using either synthetic orExpand
  • 22
  • 1
Left ventricular support device for cardiogenic shock during myocardial infarction due to stent thrombosis: a single centre experience.
BACKGROUND Stent thrombosis (ST) is a new, rare, cause of STEMI. Few data are available about incidence and clinical impact of shock complicating acute myocardial infarction due to ST (st-STEMI). Expand
  • 5
  • 1
Safety and efficacy of the AngioJet in patients with acute myocardial infarction: results from the Florence Appraisal Study of Rheolytic Thrombectomy (FAST).
OBJECTIVES To assess the safety and efficacy of the AngioJet coronary device, given the uncertain risk-benefit balance of rheolytic thrombectomy in patients with acute myocardial infarction (AMI). Expand
  • 16
[Percutaneous rheolytic thrombectomy with AngioJet for pulmonary embolism: methods and results in the experience of a high-volume center].
BACKGROUND Pulmonary embolism is a common disease with significant mortality. Anticoagulant and thrombolytic therapies are a mainstay in the management of acute pulmonary embolism, especially withExpand
  • 10
Thrombus aspiration with export catheter in ST elevation myocardial infarction.
BACKGROUND Many thrombectomy devices have failed to confirm initial promising results during primary angioplasty. This may be due to device complexity and operator experience. The objective of thisExpand
  • 17
Early and long-term clinical results of AngioJet rheolytic thrombectomy in patients with acute pulmonary embolism.
Anticoagulant and thrombolytic therapies are a mainstay in the management of acute pulmonary embolism (PE), especially when hemodynamic compromise is present. However, systemic drugs cannot achieveExpand
  • 49